Key Takeaways
- Volume-led recovery taking shape: India business volume growth hit multi-year highs in FY26, and management expects Parachute volume to visibly pick up from Q1 FY27 as copra-led price cuts flow through.
- Portfolio transformation is accelerating: Foods and Premium Personal Care reached 23% of revenue in FY26, ahead of the earlier 25% target, and the aspiration is now ~27% in FY27 and one-third by FY30.
- Margin expansion story has legs: Management guided to 150–200 bps operating margin expansion in FY27 and flagged 300–400 bps gross margin expansion over the FY26 exit as "fairly possible," anchored on rangebound copra and digital-business profitability.
- Competitive moat is widening, not shrinking: Supply-chain constraints and working-capital stress are neutralizing copra deflation for smaller players, so Marico expects to gain share even as input costs fall, a dynamic that historically favored unorganized competitors.
- What to watch next quarter: Whether Parachute volumes actually inflect, the trajectory of copra and crude-linked inputs as geopolitical tensions evolve, and the pace of profitability improvement in Plix and other digital-first brands.
India Demand & Volume Recovery
- Multi-year volume high: India business delivered its strongest volume growth in several years during FY26, supported by benign inflation, improving rural sentiment, policy stimulus, and GST rate rationalization.
- Rural-led, urban-following: The second-half consumption acceleration was driven by rural recovery, which management expects to be followed by urban recovery, aided by affordability gains from price drops and low overall inflation.
- Unbranded-to-branded tailwind: GST rationalization, which brought food categories to a uniform 5% rate, is accelerating the shift from unbranded to branded consumption, a structural tailwind Marico is positioned to capture.
- Parachute inflection point: After carrying flat volumes through a 60% price increase, Parachute is now seeing price cuts of ~10% on non-price-point and small packs; management expects a consumption recovery with volume growth "evidently visible from Q1 FY27 itself."
- The elasticity puzzle: The fact that Parachute held volume flat despite a 60% price rise challenges Marico's historical pricing model, and management acknowledged a possible recalibration of that model "over the next couple of years."
Saugata Gupta: "I believe if I have 8 to 10 vectors of growth, and they are in a symphony, 1 or 2 strings not working, even then we are pretty confident of delivering what we are seeking to achieve."
Portfolio Transformation: Foods & Premium Personal Care
- Scale with profitability: The combined Foods and Premium Personal Care portfolio exited FY26 at 23% of revenue, with Foods alone crossing ₹1,000 crores. Management now targets ~27% share in FY27 and aspires to move to one-third of the business by FY30.
- Foods growth reset to 20%+: Core Saffola Foods grew double digits in Q4, and the base-case growth expectation going forward is at least 20%, with results visible from Q1 FY27. Overall Foods growth of 16–17% in FY26 was held back by True Elements lapping a high base and SKU rationalization on low-margin products.
- Premium Personal Care profitability path: Beardo and Plix remain on an accelerated growth trajectory with improving profitability. Management aims to exit FY27 at double-digit EBITDA margins for the segment and reach teens by FY30.
- Plix pivot to Personal Care: Plix is being repositioned as a plant-based hair and skin food brand, with its center of gravity shifting toward Personal Care, where profitability is higher and the addressable market is larger. D2C now accounts for 45% of Plix sales.
- Acquisition integration on track: 4700BC, Cosmix, Skinetiq, and Plix are all described as positive starts with no hiccups. Cosmix and Skinetiq are already profitable (high-teens and mid-20s EBITDA margins respectively), and Plix is on an upward margin trajectory with back-end synergies supporting long-term profitability.
Saugata Gupta: "For me, any day, I will vote for a 20%, 25% growth with steady increase in profitability over a 60% growth without any increase in profitability."
Margin Outlook & Input Costs
- Divergent input cost picture: Copra prices have corrected ~35% from their peak and are expected to remain rangebound, while vegetable oils and other crude-linked inputs face upward bias from Middle East geopolitical tensions. The weighted average input cost increase for FY27 is "extremely marginal."
- Gross margin expansion anchored: Management stated that full-year gross margin expansion of 300–400 bps over the FY26 exit is "fairly possible," with the low-cost copra base beginning to flow through from Q1 FY27.
- Operating margin base case: 150–200 bps of operating margin expansion is the base case for FY27, supported by gross margin gains, improving digital-business profitability, and portfolio synergies.
- A&P investment rising: Advertising and promotion spend is expected to increase by 200–250 bps from current levels, reflecting continued investment behind brand building and digital capabilities.
- Price actions already taken: Price hikes to neutralize input cost impacts were implemented in March for the affected portfolio, and a 6–7% price increase was taken in VAHO in response to crude derivative increases.
Pawan Agrawal: "I believe for full year, about 300 to 400 basis points improvement over the exit of FY '26 is fairly possible."
Competitive Dynamics & Supply Chain
- Smaller players squeezed: Even in a copra deflationary environment, smaller competitors face constraints in polymers, packaging material, and fuel, plus working-capital limitations that prevent them from stocking or position-building during high inflation. Marico's supply-chain assurance and back-end advantages are expected to act as a competitive moat.
- Deflation without the usual threat: Historically, copra deflation brought smaller players back into the market. Management now believes that other input-cost inflation has neutralized the copra benefit for them, so they are "no longer active that much" even as copra prices fall.
- Parachute cross-subsidization: Price cuts on Parachute have been selective (non-price-point and small packs only, no grammage increases), with a portfolio approach to cross-subsidization that protects profitability while passing benefits to consumers.
Saugata Gupta: "Normally in a deflationary environment, they become active. we have reasons to believe they are no longer active that much even if there is a deflationary environment in copra because all the other things have neutralized that copra impact for them."
International Business
- Broad-based momentum: International business delivered robust growth in FY26, with Bangladesh maintaining strong momentum and Vietnam, South Africa, and export markets scaling up as key growth engines.
- Bangladesh acceleration: Growth of 22%, 29%, and 35% over the last three quarters reflects good performance in both the core portfolio and newer categories like shampoo and baby care, plus decent volume growth. Management cautioned against reading too much into quarterly swings but expects at least double-digit growth for sure.
- MENA supply-side hiccup: The Gulf region was impacted by near-term supply-side constraints in March, while Egypt continued its strong growth trajectory.
- Mid-teens CC growth target: Management expects to maintain mid-teen constant currency growth in the international business, supported by broad-based performance across markets and portfolio diversification.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| India volume growth | High single-digit volume growth | FY27 |
| Consolidated revenue | Cross ₹15,000 crores (double-digit growth) | FY27 |
| Consolidated EBITDA growth | High-teen growth | FY27 |
| Operating margin expansion | 150–200 bps expansion | FY27 |
| Gross margin expansion | 300–400 bps over FY26 exit | FY27 (full year) |
| International business growth | Mid-teens constant currency growth | FY27 |
| Foods growth | At least 20%, base case 20–25% | FY27 and beyond |
| New business revenue share | ~27% of consolidated revenue | FY27 exit |
| Premium Personal Care EBITDA margin | Double-digit | FY27 exit |
| Premium Personal Care EBITDA margin | Teens | FY30 |
| New business revenue share | ~One-third of consolidated revenue | FY30 |
| Consolidated revenue aspiration | Comfortably cross ₹20,000 crores | FY30 |
| Consolidated EBITDA growth aspiration | Mid-teen growth | FY30 |
| Commodity-linked business share | Reduce from >70% to ~50% | Over a decade |
| Parachute volume recovery | Visible pickup in volume growth | From Q1 FY27 |
| Consolidated tax rate | Around 20% | FY27 |
| Bangladesh growth | At least double-digit | FY27 |
| A&P spend increase | 200–250 bps above current levels | FY27 |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Consolidated revenue | ₹15,000+ cr (FY27 target), double-digit growth expected |
| India volume growth | High single-digit expected for FY27 |
| International constant currency growth | Mid-teen expected for FY27 |
| Consolidated EBITDA growth | High-teen expected for FY27, subject to stable macros |
| Operating margin | ~17% for FY26; 150–200 bps expansion base case for FY27 |
| Gross margin expansion | 350–400 bps expected for FY27 over FY26 exit |
| A&P spend increase | 200–250 bps expected for FY27 |
| Parachute volume growth | Low single-digit, after adjusting for mlage adjustments |
| Value Added Hair Oils volume growth | Low 20s in Q4; 20% growth in FY26 |
| Foods portfolio revenue | ₹1,000+ cr exit FY26; 16–17% growth in Q4 |
| Premium Personal Care ARR | ₹350+ cr (Serums, Male Grooming, Skin Care) |
| Digital-first portfolio ARR | ₹1,100+ cr exit FY26 |
| Foods and Premium Personal Care revenue share | 23% of India business in FY26, expected to reach ~27% in FY27 |
| Bangladesh sales growth | 35% in Q4 vs 25% full-year growth |
| Copra price decline from peak | ~35% |
| Parachute price cut | ~10% on non-price-point and small packs [7–8] |
| VAHO price increase | 6–7% taken in response to crude derivative increases |
| Consolidated tax rate | ~20% expected for FY27 |
| Plix EBITDA margin | Mid to high single-digit currently |
| Plix D2C share | ~45% of business |
| FY30 revenue target | ₹20,000+ cr, with mid-teen EBITDA growth aspiration |